(Q44436724)

3 December 2017

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications (English)

1 reference

3 December 2017

1 reference

liver transplantation

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

1 January 2024

author name string

Michael Wachs

3

1 reference

3 December 2017

Thomas Bak

4

1 reference

3 December 2017

Marcello Kugelmas

5

1 reference

3 December 2017

Tracy Steinberg

6

1 reference

3 December 2017

Igal Kam

8

1 reference

3 December 2017

Jeffrey C. Dunkelberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740787

1 January 2024

James F. Trotter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740787

1 January 2024

Gregory T. Everson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740787

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12740787

1 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://doi.org/10.1053/jlts.2003.50079

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740787

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjlts.2003.50079

1 January 2024

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

https://onlinelibrary.wiley.com/doi/full/10.1053/jlts.2003.50079

1 January 2024

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

1 January 2024

published in

Liver Transplantation

1 reference

3 December 2017

9

1 reference

3 December 2017

5

1 reference

3 December 2017

463-468

1 reference

Sirolimus: a potent new immunosuppressant for liver transplantation

3 December 2017

1

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

mTOR inhibitors: an overview

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

1 January 2024

13

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Rapamycin inhibits vascular smooth muscle cell migration

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Rescue of liver grafts from hepatic artery occlusion in living-related liver transplantation

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

The effect of surgical site infections on outcomes and resource utilization after liver transplantation

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Vascular complications after orthotopic liver transplantation

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation.

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1053/JLTS.2003.50079

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference